Article

Capitol Hill briefing focuses on glaucoma in minorities

A pair of glaucoma specialists spoke during a Capitol Hill briefing Sept. 8 to discuss the effect of the disease on minorities.

A pair of glaucoma specialists spoke during a Capitol Hill briefing Sept. 8 to discuss the effect of the disease on minorities.

Mildred Olivier, MD, FACS, reported on the recently released National Eye Institute (NEI) study on the use of pressure-reducing drops to delay or prevent glaucoma in African-Americans. She also addressed NEI's efforts to educate affected populations about its vision disparities research.

Dr. Olivier is president and chief executive officer of the Midwest Glaucoma Center PC in Chicago. She is an assistant clinical professor in the department of ophthalmology at the Olympia Fields Osteopathic Medical Center and Cook County Hospital.

Rohit Varma, MD, MPH, reported on the Los Angeles Latino Eye Study (LALES), a comprehensive epidemiological analysis of visual impairment in Latinos. Dr. Varma is an associate professor of ophthalmology at the Keck School of Medicine's Doheny Eye Institute at the University of Southern California.

The results of the study, released Aug. 9 and published in the June, July, and August 2004 issues of Ophthalmology, show that Latinos had high rates of open-angle glaucoma and diabetic retinopathy. (Details of the LALES study will appear in an upcoming issue of Ophthalmology Times.)

The Alliance for Eye and Vision Research sponsored the briefing, titled "Vision Health Disparities Research."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.